Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Michael, Unterhalt"'
Autor:
Carsten Hirt, Eva Hoster, Michael Unterhalt, Mathias Hänel, Gabriele Prange-Krex, Roswitha Forstpointner, Axel Florschütz, Ullrich Graeven, Norbert Frickhofen, Gerald Wulf, Eva Lengfelder, Christian Lerchenmüller, Rudolf Schlag, Judith Dierlamm, Ludwig Fischer von Weikersthal, Asima Ahmed, Hanns-Detlev Harich, Andreas Rosenwald, Wolfram Klapper, Martin Dreyling, Wolfgang Hiddemann, Michael Herold
Publikováno v:
HemaSphere, Vol 5, Iss 7, p e600 (2021)
The German study groups, the German Low-Grade Lymphoma Study Group (GLSG) and Ostdeutsche Studiengruppe Hämatologie und Onkologie (OSHO), initiated in 2007 a double randomized trial to investigate efficacy and safety of rituximab maintenance versus
Externí odkaz:
https://doaj.org/article/7f58ca3174b5414e8506396f6d40af2b
Autor:
Martin Dreyling, Jeanette K. Doorduijn, Eva Gine, Mats Jerkeman, Jan Walewski, Martin Hutchings, Ulrich Mey, Jon Riise, Marek Trneny, Vibeke K.J. Vergote, Melania Celli, Ofer Shpilberg, Maria Gomes da Silva, Sirpa Leppa, Linmiao Jiang, Christiane Pott, Wolfram Klapper, Döndü Gözel, Christian Schmidt, Michael Unterhalt, Marco Ladetto, Eva Hoster
Publikováno v:
Blood. 140:1-3
Autor:
Gabriel Scheubeck, Linmiao Jiang, Olivier Hermine, Hanneke Kluin-Nelemans, Christian Schmidt, Michael Unterhalt, Andreas Rosenwald, Wolfram Klapper, Andrea Evangelista, Marco Ladetto, Mats Jerkeman, Simone Ferrero, Martin Dreyling, Eva Hoster
Currently, treatment allocation of patients with Mantle Cell Lymphoma (MCL) is mainly based on age and medical fitness. The combined MCL International Prognostic Index (MIPI-c) allows to predict prognosis using clinical factors (MIPI) and the Ki-67 i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5cad63ca71f2b2c139c24728c02db71
https://doi.org/10.21203/rs.3.rs-2658207/v1
https://doi.org/10.21203/rs.3.rs-2658207/v1
Autor:
Stefan Alig, Vindi Jurinovic, Alessandro Pastore, Deepak Bararia, Sarah Häbe, Johannes C. Hellmuth, Robert Kridel, Randy Gascoyne, Christian Schmidt, Anna-Katharina Zöllner, Christian Buske, Martin Dreyling, Michael Unterhalt, Wolfgang Hiddemann, Eva Hoster, Oliver Weigert
Publikováno v:
Haematologica, Vol 103, Iss 8 (2018)
Externí odkaz:
https://doaj.org/article/478a70586fc84a1594a3b12415030b14
Autor:
Liat Vidal, Anat Gafter-Gvili, Martin Dreyling, Michele Ghielmini, Mathias Witzens-Harig, Ofer Shpilberg, Michael Unterhalt, Mathias Rummel, Ronit Gurion
Publikováno v:
HemaSphere, Vol 2, Iss 4 (2018)
Abstract. Current treatment of patient with mantle cell lymphoma (MCL) is insufficient and does not result in cure. To assess the efficacy and safety of maintenance therapy for patients with MCL, we performed a systematic review and meta-analysis of
Externí odkaz:
https://doaj.org/article/47248c88673542ec87f55becdcc24b67
Autor:
Hanneke C. Kluin-Nelemans, Martin Dreyling, Christian Schmidt, Catherine Thieblemont, Kai Hübel, Wolfgang Hiddemann, Vibeke Vergote, Jürgen Krauter, Max S. Topp, Wolfram Klapper, Bernd Metzner, Achiel Van Hoof, Lorenz Truemper, Kerstin Schäfer-Eckart, Georg Lenz, Kamal Bouabdallah, Marc André, Stephan Stilgenbauer, Jan Dürig, Eva Hoster, Anna-Katharina Zoellner, Michael Unterhalt
Publikováno v:
Lancet Haematology, 8(9), e648-e657. ELSEVIER SCI LTD
BACKGROUND Autologous haematopoietic stem-cell transplantation (HSCT) in first remission is the current standard treatment in fit patients with mantle cell lymphoma. In this long-term follow-up study, we aimed to evaluate the efficacy of autologous H
Autor:
Veit L Buecklein, Maximilian Warm, Karsten Spiekermann, Christian Schmidt, Michael Unterhalt, Naval Daver, Marion Subklewe
Publikováno v:
Blood. 140:3227-3228
Autor:
Alfred C. Feller, Harald Stein, Wolfram Klapper, Andreas Rosenwald, Vindi Jurinovic, Michael Unterhalt, Verena Passerini, William David Keay, Christiane Pott, Annette M. Staiger, Stefan Alig, German Ott, Heike Horn, Sarah Haebe, Erik Gaitzsch, Mohammad Shahrokh Esfahani, Ash A. Alizadeh, Natyra Tahiri, Martin Dreyling, Johannes C. Hellmuth, Christian Schmidt, Eva Hoster, Martin-Leo Hansmann, Oliver Weigert, Wolfgang Hiddemann, Anna-Katharina Zoellner
Publikováno v:
Blood Adv
High-dose therapy and autologous stem cell transplantation (HDT/ASCT) is an effective salvage treatment for eligible patients with follicular lymphoma (FL) and early progression of disease (POD). Since the introduction of rituximab, HDT/ASCT is no lo
Autor:
Hervé Tilly, Gilles Salles, Wolfram Klapper, Stephan Stilgenbauer, Martin Dreyling, Christian Schmidt, Michael Unterhalt, Pierre Feugier, Eva Hoster, Christiane Pott, Josée M. Zijlstra, Lothar Kanz, Jan Walewski, Vincent Ribrag, Michal Szymczyk, Jeanette K. Doorduijn, Olivier Hermine, Marek Trneny, Christian H. Geisler, Florian Kaiser, Hanneke C. Kluin-Nelemans, Catherine Thieblemont
Publikováno v:
Journal of Clinical Oncology, 38(3), 248-256. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 38(3), 248-+. American Society of Clinical Oncology
Kluin-Nelemans, H C, Hoster, E, Hermine, O, Walewski, J, Geisler, C H, Trneny, M, Stilgenbauer, S, Kaiser, F, Doorduijn, J K, Salles, G, Szymczyk, M, Tilly, H, Kanz, L, Schmidt, C, Feugier, P, Thieblemont, C, Zijlstra, J M, Ribrag, V, Klapper, W, Pott, C, Unterhalt, M & Dreyling, M H 2020, ' Treatment of Older Patients With Mantle Cell Lymphoma (MCL) : Long-Term Follow-Up of the Randomized European MCL Elderly Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, no. 3, pp. 248-256 . https://doi.org/10.1200/JCO.19.01294
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 38(3), 248-256. American Society of Clinical Oncology
Journal of Clinical Oncology, 38(3), 248-+. American Society of Clinical Oncology
Kluin-Nelemans, H C, Hoster, E, Hermine, O, Walewski, J, Geisler, C H, Trneny, M, Stilgenbauer, S, Kaiser, F, Doorduijn, J K, Salles, G, Szymczyk, M, Tilly, H, Kanz, L, Schmidt, C, Feugier, P, Thieblemont, C, Zijlstra, J M, Ribrag, V, Klapper, W, Pott, C, Unterhalt, M & Dreyling, M H 2020, ' Treatment of Older Patients With Mantle Cell Lymphoma (MCL) : Long-Term Follow-Up of the Randomized European MCL Elderly Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, no. 3, pp. 248-256 . https://doi.org/10.1200/JCO.19.01294
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 38(3), 248-256. American Society of Clinical Oncology
PURPOSE In an update of the randomized, open-label, phase III European Mantle Cell Lymphoma (MCL) Elderly trial (ClinicalTrials.gov identifier: NCT00209209 ), published in 2012, we aimed to confirm results on long-term outcome focusing on efficacy an
Autor:
Diego Villa, Eva Hoster, Olivier Hermine, Wolfram Klapper, Michal Szymczyk, André Bosly, Michael Unterhalt, Lisa M. Rimsza, Colleen A. Ramsower, Ciara L. Freeman, David W. Scott, Alina S. Gerrie, Kerry J. Savage, Laurie H. Sehn, Martin Dreyling
Publikováno v:
Blood advances, Vol. 6, no. 18, p. 5285-5294 (2022)
The objective of this study was to explore differences in outcomes between first-line rituximab plus bendamustine (R-B) and R-CHOP/R-DHAP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone, dexamethasone, cytarabine, cisplatin) in tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19cbeec5c43204912d6bb02bbe887781
https://hdl.handle.net/2078.1/260713
https://hdl.handle.net/2078.1/260713